Compare

Immunic, Inc. vs Kiora Pharmaceuticals Inc vs HCW Biologics Inc. vs BriaCell Therapeutics Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearImmunic, Inc.
IMUX
Kiora Pharmaceuticals Inc
KPRX
HCW Biologics Inc.
HCWB
BriaCell Therapeutics Corp.
BCTX
Year ended2025-12-312025-12-312025-12-312026-07-31
Revenuen/a$0$54.2Kn/a
Revenue growth (YoY)n/a-100.0%-97.9%n/a
Gross marginn/an/a20.0%n/a
Operating marginn/an/an/mn/a
Net marginn/an/an/mn/a
Net income-$97.17M-$10.84M-$7.96M-$34.90M
EPS (Diluted)-$0.62-$2.64-$10.63-$6.97
Operating cash flow-$85.81M-$9.96M-$13.39M-$28.65M
Free cash flow-$85.97M-$10.07M-$13.39M-$28.78M
Cash & equivalents$15.48M$8.70M$1.95M$9.85M
Total assets$24.05M$24.25M$24.52M$23.58M
Total liabilities$30.73M$8.13M$21.76Mn/a
Shareholders' equity-$6.67M$16.13M$2.76M$15.56M
Return on year-end equityn/a-67.2%-287.9%-224.3%
Shares outstanding90.15M3.76Mn/a8.71M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearImmunic, Inc.Kiora Pharmaceuticals IncHCW Biologics Inc.BriaCell Therapeutics Corp.
Latestn/a$0
Ended 2025-12-31
$54.2K
Ended 2025-12-31
n/a
1 year earliern/a$16.02M
Ended 2024-12-31
$2.57M
Ended 2024-12-31
n/a
2 years earliern/a$0
Ended 2023-12-31
$2.84M
Ended 2023-12-31
n/a
3 years earliern/an/a$6.72M
Ended 2022-12-31
n/a
4 years earliern/a$0
Ended 2021-12-31
$0
Ended 2021-12-31
n/a